Changing the Standard of Care for Patients with RET+ Advanced Thyroid Cancer
Date & Time: October 16th, 2:00 PM 2:40 PM EST
Speaker: Dr. Matthew Taylor
This session will review how to identify RET+ advanced thyroid cancers and provide an overview of an approved RET inhibitor for treatment. The overview will include clinical trial data, safety information, and dosing recommendations. This session will also review hypothetical cases of patients with RET+ advanced thyroid cancer, from identification to management.